Rebić Damir, Rašić Senija, Rebić Velma
Clinic for Nephrology, Clinical Center of Sarajevo University, Bolnička 25, 71000 Sarajevo, Bosnia and Herzegovina.
Int J Nephrol. 2013;2013:681454. doi: 10.1155/2013/681454. Epub 2013 Oct 22.
Diabetes mellitus (DM) is the leading cause of the end-stage renal disease (ESRD). Vascular diseases are the most common cause of morbidity and mortality in the chronic kidney disease. The aim of this study was to analyze the impact of peritoneal dialysis (PD) treatment on morphologic and hemodynamic vascular parameters of carotid arteries in diabetic type 2 and nondiabetic patients with ESRD during the period of one year after the start of PD treatment using ultrasonography of carotid arteries and their relation on uremia and PD inherent factors. Mean intima-media thickness, plaque score, peak systolic velocity, end-diastolic velocity, and carotid diameter significantly decreased 12 months after PD treatment start in both groups. Significant reduction in median serum endothelin-1 concentration after 12 months on PD treatment was observed in the group of patients with DM (7.6-5.9 pg/mL) and also in group of patients without DM (3.6-3.3 pg/mL). Also median nitric oxide concentration significantly increased after 12 months on PD compared to baseline levels both in patients with DM (25.0-34.3 μ mol/L) as was observed in patients without DM (49.6-56.5 μ mol/L). PD treatment, with the regulation of these vasoactive molecules and other vascular risk factors, significantly contributes to vascular remodeling, especially in DM patients.
糖尿病(DM)是终末期肾病(ESRD)的主要病因。血管疾病是慢性肾脏病发病和死亡的最常见原因。本研究的目的是在开始腹膜透析(PD)治疗一年期间,使用颈动脉超声分析PD治疗对2型糖尿病和非糖尿病ESRD患者颈动脉形态学和血流动力学血管参数的影响,以及它们与尿毒症和PD固有因素的关系。两组患者在开始PD治疗12个月后,平均内膜中层厚度、斑块评分、收缩期峰值流速、舒张末期流速和颈动脉直径均显著降低。在接受PD治疗12个月后,糖尿病患者组(7.6 - 5.9 pg/mL)和非糖尿病患者组(3.6 - 3.3 pg/mL)的血清内皮素-1中位数浓度均显著降低。同样,与基线水平相比,糖尿病患者(25.0 - 34.3 μmol/L)和非糖尿病患者(49.6 - 56.5 μmol/L)在接受PD治疗12个月后,一氧化氮中位数浓度均显著升高。PD治疗通过调节这些血管活性分子和其他血管危险因素,显著促进血管重塑,尤其是在糖尿病患者中。